Advanced Drug Delivery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

The report on the global advanced drug delivery market provides qualitative and quantitative analysis for the period from 2021-2030. The global advanced drug delivery market was valued at USD 43.85 billion in 2022 and is expected to reach USD 137.33 billion in 2030, with a CAGR of 13.39% during the forecast period 2023-2030. The study on advanced drug delivery market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The phrase advanced drug delivery denotes the processes, preparations, and methods used to provide drugs for various applications and healing purposes. Advanced drug delivery is more precisely known as transporting the medicine particle to the estimated place. They are made to deliver drugs in a measured or modified way in the nerve or cells. It's the most secure and highly effective therapy. Advanced drug delivery is the drug delivery system that is related to the drug delivery strategies which utilize innovative technology. These types of drugs used for the treatment of disease result in a significant impact on the technology used. The advanced drug delivery market is easier, accurate requires less frequent dosing, and the variability in systemic drug concentrations is decreased.

The increasing incidence of chronic diseases within the overall population is one of the key factors that drive the market. Chronic diseases are described generally as problems that persist a year or longer and require continuous medical treatment, that limit everyday activities, or both. Furthermore, a substantial rise in healthcare expenditure worldwide has boosted the advanced drug delivery market. The key factors that are accountable for the rise in healthcare expenditure are the increase in population especially geriatrics, an increase in chronic diseases, and increased medical service utilization. Growth in healthcare spending has further increased due to the attention spread among consumers for health. Increased Research and Development will create a chance to introduce new drug particles. However, the many rises in the number of drug recalls and drug failures are anticipated to hamper the advanced drug delivery market growth within the forecast period. Furthermore, the stringent government rules and FDA approvals will restrain the market growth within the forecast period.

Among the regions, North America holds the largest market share of the advanced drug delivery market. The increasing number of patients, growing investments in R&D activities, and therefore the establishment of technically advanced research centers will contribute to the advanced drug delivery market growth within the region. Europe held the second-largest share within the global advanced drug delivery market. The expansion of the advanced drug delivery market within the region may be attributed to the rise in the strategic developments by key players. However, Asia Pacific accounted for a major share of the worldwide advanced drug delivery market in 2020, and this market within the region is predicted to grow at a rapid pace during the forecast period. An increase in the adoption of advanced technology is anticipated to fuel the expansion of the advanced drug delivery market within the region.

Report Findings

1) Drivers

• Rising prevalence of chronic diseases.
• Increasing healthcare expenditure due to various disease.

2) Restraints

• Side effects atherosclerosis drugs.
• Stringent government rules and regulations.

3) Opportunities

• Advanced research and development.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global advanced drug delivery market is segmented on the basis of type, application, and technology.

The Global Advanced Drug Delivery Market by Type

• Oral Drug Delivery System
• Injection-based Drug Delivery System
• Inhalation/Pulmonary Drug Delivery System
• Transdermal Drug Delivery System
• Carrier-based Drug Delivery System
• Other Types

The Global Advanced Drug Delivery Market by Application

• Cardiovascular Diseases
• Oncology
• Urology
• Diabetes
• Central Nervous System
• Ophthalmology
• Infections
• Other Applications

The Global Advanced Drug Delivery Market by Technology

• Prodrug
• Implants and Intrauterine Devices
• Targeted Drug Delivery
• Polymeric Drug Delivery
• Other Technologies

Company Profiles

The companies covered in the report include

• Pfizer Inc.
• AstraZeneca
• BD
• Abbott Laboratories
• Amgen Inc.
• Novartis AG
• Baxter
• Bayer AG
• Medtronic
• Kindeva Drug Delivery

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the advanced drug delivery market.
2. Complete coverage of all the segments in the advanced drug delivery market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global advanced drug delivery market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.